Navigation Links
RESPONSE to the FDA and Public Health Experts Findings on Electronic Cigarettes
Date:7/23/2009

LOS ANGELES, July 23 /PRNewswire/ -- Yesterday, the FDA announced that after laboratory analysis of electronic cigarette samples they have discovered that Electronic Cigarettes contain carcinogens and toxic chemicals. However, this does not ring true for U.S. based manufacturer, SmokeStik, LTD. The FDA report analyzed e-cigarettes cartridges and listed several compounds of concern, such as, Diethylene Glycol, Tobacco specific nitrosamines, Anabasine, and Myosmine. Independent lab results have shown that none of these compounds are present in SmokeStik products.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090723/LA51264)

SmokeStik has released the following statement:

"As a company that is categorized in the 'e-cigarette' industry, SmokeStik is both aware and concerned about the FDA's findings released yesterday regarding electronic cigarettes. While we cannot speak specifically to the components of NJOY or Smoking Everywhere's cartridges, we do understand from public sources that these cartridges are imported from China. As many of our distributors are aware, as of last month, SmokeStik's cartridges are now made domestically. Moreover, all of the ingredients in SmokeStik's cartridges are certified by independent laboratories and most importantly; do NOT contain any of the carcinogens referenced in the Final Report on FDA Analyses.

SmokeStik has always presented its products as an 'alternative' for responsible, adult smokers, and not as a smoking cessation product. SmokeStik has NEVER sold flavored cartridges such as those referenced in the FDA's Report. As a company, we oppose this type of marketing and discourage teenagers from using our products."

If you would like to speak with SmokeStik, please contact Alexis Wallsh at Entertainment Fusion Group, alexis@efgpr.com or 310.432.0020.

About SmokeStik, LTD

SmokeStik, LTD is a U.S.-based manufacturer of the alternative smoking device, SmokeStik. SmokeStik effectively replicates the smoking experience while eliminating carcinogens, secondhand smoke, odor and litter. SmokeStik poses no health risks, thereby contributing to the reduction of the leading cause of preventable death in America - tobacco; SmokeStik is available in the U.S., the EU and South America. For more information, please visit www.SmokeStik.com.


'/>"/>
SOURCE SmokeStik, LTD
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cell division find prompts overhaul of immune response modeling
2. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
3. Camp High Harbour Response to Flu Outbreak Includes SpectraSan 24 Disinfectant
4. CIFOR Guidelines for Foodborne Disease Outbreak Response Published by National Food Safety Group
5. Emdeon To Collaborate With Rx Response in Critical Pharmacy Disaster Reporting
6. Accumetrics VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly-Approved Prasugrel (Effient(R))
7. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
8. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
9. Immune Response May Speed AIDS Progression in Women
10. Statement by Jim OHara, Director, Produce Safety Project, in Response to the White House Announcement on the Proposed FDA Rule on Produce Safety
11. Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based payments, ... are unsure how to move forward, given the need to sustain current operations. ... tailored to an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... June 23, 2016 Research and ... in Europe 2016 Edition: The New Global Agenda " ... OTC Distribution in Europe - ... explores and tracks change. It identifies the driving factors coming ... the consumer healthcare industry now and in the future. It ...
(Date:6/23/2016)... June 23, 2016 The ... the development of combination therapies trend is expected ... treatment of CLL were available only in the ... are chlorambucil in combination with prednisone, and a ... a growing trend of developing combination therapies to ...
Breaking Medicine Technology: